HUP0001684A3
(en )
2001-09-28
Use of fumaric acid derivatives
GB2305605B
(en )
2000-01-12
Pipecolic acid derivatives for the treatment of neurological disorders
IL133800A0
(en )
2001-04-30
Imidazopyrimidines and imidazopyridines for the treatment of neurological disorders
SG100766A1
(en )
2003-12-26
Sulfonamides for treatment of endothelin-mediated disorders
EP1063990A4
(en )
2003-01-02
Therapy of estrogen-associated disorders
IL127496A0
(en )
1999-10-28
The use of MMP inhibitors for the treatment of ocular angiogenesis
PL340461A1
(en )
2001-02-12
Derivatives of isothiazocarboxylic acid
GB9807464D0
(en )
1998-06-10
Purification of human acid ยต-glucosidase
IL129144A0
(en )
2000-02-17
Use of 1-hydroxy-2-pyridones for the treatment of skin diseases
ZA973622B
(en )
1997-11-25
Use of forms of hyaluronic acid (HA) for the treatment of cancer.
ZA984174B
(en )
1998-11-23
Novel triptolide derivatives useful in the treatment of autoimmune diseases
HUP0104963A3
(en )
2002-11-28
Compositions for the treatment of skin diseases
PL336760A1
(en )
2000-07-17
Treatment of skin diseases
IL133089A0
(en )
2001-03-19
Novel triptolide derivatives useful in the treatment of autoimmune diseases
GB9927757D0
(en )
2000-01-26
Treatment of autoimmune diseases
IL131347A0
(en )
2001-03-19
Treatment of skin disorders
GB2326116B
(en )
2001-04-11
Treatment of chocolate
GB9922710D0
(en )
1999-11-24
Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatatives for the treatment of multiple sclerosis
HUP0100365A3
(en )
2002-06-28
Combination therapy for the treatment of aids
SI0980242T1
(en )
2003-06-30
Use of fumaric acid derivatives for the treatment of autoimmune diseases
GB9710054D0
(en )
1997-07-09
Treatment of diseases
GB9713581D0
(en )
1997-09-03
Treatment of neuropsychiatric disorders
GB9727001D0
(en )
1998-02-18
Treatment of movement disorders
SI0928193T1
(en )
2002-12-31
Use of 1-hydroxy-2-pyridones for the treatment of skin diseases
GB9726745D0
(en )
1998-02-18
Treatment of medical conditions